Development of high-yield influenza A virus vaccine viruses-Reference-Cited by-同舟云学术

Development of high-yield influenza A virus vaccine viruses

Published:2015-09-02 Issue:1 Volume:6 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Ping Jihui,Lopes Tiago J.S.,Nidom Chairul A.,Ghedin Elodie,Macken Catherine A.,Fitch Adam,Imai Masaki,Maher Eileen A.,Neumann Gabriele,Kawaoka Yoshihiro

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms9148.pdf

Reference61 articles.

1. Wright, P. F., Neumann, G. & Kawaoka, Y. in Fields Virology 6th edn (eds Knipe D. M.et al. Lippincott Williams & Wilkins (2013).

2. China—WHO Joint Mission on Human Infection with Avian Influenza A(H7N9) Virus. http://www.who.int/influenza/human_animal_interface/influenza_h7n9/ChinaH7N9JointMissionReport2013.pdf (2013).

3. Centers for Disease C, Prevention. Emergence of Avian Influenza A(H7N9) Virus Causing Severe Human Illness—China, February-April 2013. MMWR Morb Mortal Wkly Rep 62, 366–371 (2013).

4. Burnet, F. M. Influenza virus on the developing egg. I. Changes associated with the development of an egg-passage strain of virus. Br. J. Exp. Pathol. 17, 282–293 (1936).

5. Katz, J. M., Wang, M. & Webster, R. G. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J. Virol. 64, 1808–1811 (1990).

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamsters;Vaccine;2024-10

2. An avian-origin internal backbone effectively increases the H5 subtype avian influenza vaccine candidate yield in both chicken embryonated eggs and MDCK cells;Poultry Science;2024-09

3. Neutralizing antibody responses against contemporary and future influenza A(H3N2) viruses in paradoxical clades elicited by repeated and single vaccinations;Journal of Medical Virology;2024-06

4. Intranasal bivalent vaccine with recombinant Influenza Virus expressing Pneumococcal Surface Protein A (PspA) protects against Streptococcus pneumoniae and Influenza A virus infection in mice;2024-04-02

5. Assessment of the antigenic evolution of a clade 6B.1 human H1N1pdm influenza virus revealed differences between ferret and human convalescent sera;eBioMedicine;2024-03